BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23341167)

  • 1. Novel type II fatty acid biosynthesis (FAS II) inhibitors as multistage antimalarial agents.
    Schrader FC; Glinca S; Sattler JM; Dahse HM; Afanador GA; Prigge ST; Lanzer M; Mueller AK; Klebe G; Schlitzer M
    ChemMedChem; 2013 Mar; 8(3):442-61. PubMed ID: 23341167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase.
    Tallorin LC; Durrant JD; Nguyen QG; McCammon JA; Burkart MD
    Bioorg Med Chem; 2014 Nov; 22(21):6053-6061. PubMed ID: 25284249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, structural characterization by IR, (1) H, (13) C, (15) N, 2D-NMR, X-ray diffraction and evaluation of a new class of phenylaminoacetic acid benzylidene hydrazines as pfENR inhibitors.
    Samal RP; Khedkar VM; Pissurlenkar RR; Bwalya AG; Tasdemir D; Joshi RA; Rajamohanan PR; Puranik VG; Coutinho EC
    Chem Biol Drug Des; 2013 Jun; 81(6):715-29. PubMed ID: 23398677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico screening for Plasmodium falciparum enoyl-ACP reductase inhibitors.
    Lindert S; Tallorin L; Nguyen QG; Burkart MD; McCammon JA
    J Comput Aided Mol Des; 2015 Jan; 29(1):79-87. PubMed ID: 25344312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular modeling studies, synthesis, and biological evaluation of Plasmodium falciparum enoyl-acyl carrier protein reductase (PfENR) inhibitors.
    Morde VA; Shaikh MS; Pissurlenkar RR; Coutinho EC
    Mol Divers; 2009 Nov; 13(4):501-17. PubMed ID: 19347595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a rhodanine class of compounds as inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase.
    Kumar G; Parasuraman P; Sharma SK; Banerjee T; Karmodiya K; Surolia N; Surolia A
    J Med Chem; 2007 May; 50(11):2665-75. PubMed ID: 17477517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological and crystallographic evaluation of novel inhibitors of Plasmodium falciparum enoyl-ACP-reductase (PfFabI).
    Belluti F; Perozzo R; Lauciello L; Colizzi F; Kostrewa D; Bisi A; Gobbi S; Rampa A; Bolognesi ML; Recanatini M; Brun R; Scapozza L; Cavalli A
    J Med Chem; 2013 Oct; 56(19):7516-26. PubMed ID: 24063369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzothiophene carboxamide derivatives as inhibitors of Plasmodium falciparum enoyl-ACP reductase.
    Banerjee T; Sharma SK; Kapoor N; Dwivedi V; Surolia N; Surolia A
    IUBMB Life; 2011 Dec; 63(12):1101-10. PubMed ID: 22006792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and in silico screening of combinatorial library of antimalarial analogs of triclosan inhibiting Plasmodium falciparum enoyl-acyl carrier protein reductase.
    Frecer V; Megnassan E; Miertus S
    Eur J Med Chem; 2009 Jul; 44(7):3009-19. PubMed ID: 19217192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel inhibitors targeting enoyl-acyl carrier protein reductase in Plasmodium falciparum by structure-based virtual screening.
    Nicola G; Smith CA; Lucumi E; Kuo MR; Karagyozov L; Fidock DA; Sacchettini JC; Abagyan R
    Biochem Biophys Res Commun; 2007 Jul; 358(3):686-91. PubMed ID: 17509532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prioritization of active antimalarials using structural interaction profile of Plasmodium falciparum enoyl-acyl carrier protein reductase (PfENR)-triclosan derivatives.
    Kumar SP; George LB; Jasrai YT; Pandya HA
    SAR QSAR Environ Res; 2015; 26(1):61-77. PubMed ID: 25567142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Based Design and Pharmacophore-Based Virtual Screening of Combinatorial Library of Triclosan Analogues Active against Enoyl-Acyl Carrier Protein Reductase of
    Bieri C; Esmel A; Keita M; Owono LCO; Dali B; Megnassan E; Miertus S; Frecer V
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel antiplasmodial compound: integration of
    Costa Júnior DB; Araújo JSC; Oliveira LM; Neri FSM; Moreira POL; Taranto AG; Fonseca AL; Varotti FP; Leite FHA
    J Biomol Struct Dyn; 2022 Sep; 40(14):6295-6307. PubMed ID: 33554762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico evaluation and in vitro growth inhibition of Plasmodium falciparum by natural amides and synthetic analogs.
    da Silva MA; Veloso MP; de Souza Reis K; de Matos Passarini G; Dos Santos APA; do Nascimento Martinez L; Fokoue HH; Kato MJ; Teles CBG; Kuehn CC
    Parasitol Res; 2020 Jun; 119(6):1879-1887. PubMed ID: 32382989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Octadecynoic acid as a dual life stage inhibitor of Plasmodium infections and plasmodial FAS-II enzymes.
    Carballeira NM; Bwalya AG; Itoe MA; Andricopulo AD; Cordero-Maldonado ML; Kaiser M; Mota MM; Crawford AD; Guido RV; Tasdemir D
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4151-7. PubMed ID: 25103602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections.
    Tasdemir D; Sanabria D; Lauinger IL; Tarun A; Herman R; Perozzo R; Zloh M; Kappe SH; Brun R; Carballeira NM
    Bioorg Med Chem; 2010 Nov; 18(21):7475-85. PubMed ID: 20855214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SAR and pharmacophore models for the rhodanine inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase.
    Kumar G; Banerjee T; Kapoor N; Surolia N; Surolia A
    IUBMB Life; 2010 Mar; 62(3):204-13. PubMed ID: 20131353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, development, synthesis, and docking analysis of 2'-substituted triclosan analogs as inhibitors for Plasmodium falciparum enoyl-ACP reductase.
    Kapoor N; Banerjee T; Babu P; Maity K; Surolia N; Surolia A
    IUBMB Life; 2009 Nov; 61(11):1083-91. PubMed ID: 19859979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 1: 4'-substituted triclosan derivatives.
    Freundlich JS; Anderson JW; Sarantakis D; Shieh HM; Yu M; Valderramos JC; Lucumi E; Kuo M; Jacobs WR; Fidock DA; Schiehser GA; Jacobus DP; Sacchettini JC
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5247-52. PubMed ID: 16198563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.